These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 6625377)

  • 41. Prevalence of markers of hepatitis B virus infection in various countries: a WHO collaborative study.
    Sobĕslavský O
    Bull World Health Organ; 1980; 58(4):621-8. PubMed ID: 6969134
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis B virus markers, alpha-fetoprotein and survival in fulminant viral hepatitis.
    Pastore G; Dentico P; Angarano G; Zanetti AR; Ferroni P; Frappampina V; Schiraldi O; Roggendorf M; Frösner G
    J Med Virol; 1981; 7(2):97-103. PubMed ID: 6167671
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estimate of the risk of post transfusion hepatitis B in Jakarta, Indonesia.
    Mboi N; Olson JG; McGreevy PB; Tan R; Moeslichan S
    Int J Epidemiol; 1981 Dec; 10(4):367-72. PubMed ID: 7327835
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recent changes in serological markers of hepatitis B virus infection in Japanese university students.
    Nakamura S
    Tohoku J Exp Med; 1985 Oct; 147(2):213-6. PubMed ID: 4082178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The interrelationships of hepatitis B e antigen antibody and HBsAg-circulating immune complexes in asymptomatic HBsAg carriers].
    Chang ML; Chou CT; Lee CF; Chang DM
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Nov; 21(4):224-9. PubMed ID: 3256466
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis B virus associated membranous glomerulonephritis.
    Wiggelinkhuizen J; Sinclair-Smith C; Stannard LM; Smuts H
    Arch Dis Child; 1983 Jul; 58(7):488-96. PubMed ID: 6870328
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A large-scale analysis study on the clinical and viral characteristics of hepatitis B infection with concurrence of hepatitis B surface or E antigens and their corresponding antibodies.
    Xiang Y; Chen P; Xia JR; Zhang LP
    Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252163
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma.
    Alward WL; McMahon BJ; Hall DB; Heyward WL; Francis DP; Bender TR
    J Infect Dis; 1985 Apr; 151(4):604-9. PubMed ID: 2982971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vertical transmission of HBV from mothers HBsAg positive, anti-HBe positive.
    Gussetti N; Pornaro E; Largajolli G; D'Elia R
    Dev Biol Stand; 1983; 54():405-8. PubMed ID: 6653895
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Radioimmunological determination of HBeAg/anti-HBe in HBsAg-positive liver diseases and in "healthy" HBsAg carriers].
    Arnold W; Hess G; Dormeyer HH; Gahl G; Hoffmann HG; Knolle J; Schönborn H
    Z Gastroenterol; 1979 Oct; 17(10):704-12. PubMed ID: 118595
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Study of hepatitis type B during hemodialysis].
    Anan'ev VA; Mikhaĭlov MI; Viazov SO; Ogareva NA; Iarmolenskiĭ IS
    Vopr Virusol; 1979; (2):125-30. PubMed ID: 433241
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Primary hepatocellular carcinoma and hepatitis B virus infection in Korea.
    Chung WK; Sun HS; Park DH; Minuk GY; Hoofnagle JH
    J Med Virol; 1983; 11(2):99-104. PubMed ID: 6188801
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Leprosy and hepatitis B virus markers: incidence of HBsAg and HBeAg in Somalian patients.
    Nuti M; Tarabini G; Palermo P; Tarabini GL; Thamer G
    Int J Lepr Other Mycobact Dis; 1979 Dec; 47(4):580-4. PubMed ID: 122628
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serological evidence of hepatitis B infection in patients with chronic liver diseases: radioimmunoassay of HBsAg and anti-HBs.
    Skinhöj P; Nielsen JO; Dietrichson O
    Scand J Gastroenterol; 1977; 12(5):615-9. PubMed ID: 918556
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis B virus infection in allogeneic bone marrow transplantation.
    Ustün C; Koç H; Karayalcin S; Akyol G; Gürman G; Ilhan O; Akan H; Ozcan M; Arslan O; Konuk N; Uysal A; Beksaç M
    Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Infections with the hepatitis B virus associated delta agent in an isolated West-African community.
    Goudsmit J; van der Waals F; Ponzetto A; Forzani B; Dobbelaar C
    J Trop Med Hyg; 1984 Dec; 87(6):257-62. PubMed ID: 6534990
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of HBeAg and HBsAg seroconversion in patients with chronic hepatitis B.
    Stránský J; Chlumská A; Zichová M; Helm R; Mankovecký L; König J
    Sb Lek; 1993; 94(4):317-25. PubMed ID: 7992018
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis B viral markers in surface antigen negative blood donors: the need to look beyond antibody negativity.
    Salawu L; Adegoke AO; Aboderin AO; Huraina HA
    West Afr J Med; 2011; 30(4):292-5. PubMed ID: 22669836
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Markers of hepatitis B virus infection in asymptomatic drug abusers in Malaysia.
    Mangalam S; Tan DS; Vijayamalar B; Collett D; Fang R
    Southeast Asian J Trop Med Public Health; 1986 Jun; 17(2):209-13. PubMed ID: 3787308
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Seroepidemiology of viral hepatitis: correlation with clinical findings.
    Miller DJ
    Postgrad Med; 1980 Sep; 68(3):137-41, 144-8. PubMed ID: 6253973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.